Yale University Exits Cartesian Therapeutics Inc, Impacting Portfolio by -66.5%

GuruFocus
15 Feb

Insight into Yale University (Trades, Portfolio)'s Strategic Investment Moves

Yale University (Trades, Portfolio) recently submitted its 13F filing for the fourth quarter of 2024, offering a glimpse into its strategic investment decisions during this period. The Yale Investment Office is dedicated to achieving high inflation-adjusted returns to support the university's current and future needs. Their approach involves establishing a risk-adjusted asset allocation and forming long-term partnerships with managers who provide deep analytical insights and enhance the operations of both public and private businesses. Yale's portfolio is crafted using a blend of academic theory and market judgment, relying on mean-variance analysis, a method developed by Nobel laureates James Tobin and Harry Markowitz at Yale’s Cowles Foundation. The Investments Office, under the guidance of Yale's Investment Committee, manages the university's Endowment, which comprises thousands of funds with various purposes and restrictions. Approximately three-quarters of the Endowment is true endowment, while the remaining quarter is quasi-endowment, treated as endowment by the Yale Corporation.

Summary of New Buy

Yale University (Trades, Portfolio) added a total of two stocks to its portfolio in the fourth quarter of 2024. The most significant addition was Ring Energy Inc (REI, Financial), with 12,667 shares, accounting for 2.11% of the portfolio and a total value of $17,230. The second largest addition was Allurion Technologies Inc (ALUR, Financial), consisting of 12,253 shares, representing approximately 0.65% of the portfolio, with a total value of $5,270.

Summary of Sold Out

Yale University (Trades, Portfolio) completely exited one holding in the fourth quarter of 2024:

  • Cartesian Therapeutics Inc (RNAC, Financial): Yale University (Trades, Portfolio) sold all 100,000 shares, resulting in a -66.5% impact on the portfolio.

Key Position Reduces

Yale University (Trades, Portfolio) also reduced its position in one stock. The most significant change was:

  • Reduced iShares Core S&P Total U.S. Stock Market ETF (ITOT, Financial) by 300 shares, resulting in a -4.64% decrease in shares and a -1.55% impact on the portfolio. The stock traded at an average price of $129.56 during the quarter and has returned 3.13% over the past three months and 4.32% year-to-date.

Portfolio Overview

At the end of the fourth quarter of 2024, Yale University (Trades, Portfolio)'s portfolio included three stocks. The top holdings were 97.24% in iShares Core S&P Total U.S. Stock Market ETF (ITOT), 2.11% in Ring Energy Inc (REI, Financial), and 0.65% in Allurion Technologies Inc (ALUR, Financial).

The holdings are primarily concentrated in two of the 11 industries: Energy and Healthcare.

This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10